Article info

Download PDFPDF

Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense
  1. Correspondence to:
    Associate Professor R F van Vollenhoven
    Department of Rheumatology, Karolinska Hospital, D2-1, 17176 Stockholm, Sweden; ronald.vanvollenhovenks.se
View Full Text

Citation

van Vollenhoven R, Harju A, Brannemark S, et al
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense

Publication history

  • Accepted June 29, 2002
  • First published November 21, 2003.
Online issue publication 
November 21, 2003

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.